Take simethicone separately
Phase 3Small molecule
Take simethicone separately is one of 9 small molecule programs targeting Bowel Preparation. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Bowel Preparation
#DrugCompanyPhaseTrials
1Resotran
TakedaPhase 3
Dulcolax
Boehringer IngelheimPhase 3
Mechanical Bowel Preparation
HHelsinki University Central Hospital
Phase 3
Take simethicone separately
TThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 3
Reglan
IIstituto Clinico Humanitas
Preclinical
Senna
MMedtronic - MITG
Preclinical
PEG-ELS
FerringPreclinical
Plenvu
JJohannes Gutenberg University Mainz
Preclinical
CLENPIQ
FerringPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Bowel Preparation1 trial
The Study on the Effect of Different Administration Methods of Simethicone in Reducing Bubbles During Bowel Preparation
Not yet recruiting·TThe Fourth Affiliated Hospital of Zhejiang University School of Medicine·Phase 4·NCT06919120·3 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Take simethicone separately. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details